Your browser is no longer supported. Please, upgrade your browser.
AIkido Pharma Inc.
Index- P/E- EPS (ttm)-1.02 Insider Own0.10% Shs Outstand35.04M Perf Week-7.87%
Market Cap73.32M Forward P/E- EPS next Y- Insider Trans53.61% Shs Float32.96M Perf Month-9.77%
Income-12.30M PEG- EPS next Q- Inst Own8.60% Short Float2.07% Perf Quarter-46.69%
Sales- P/S- EPS this Y73.60% Inst Trans215.71% Short Ratio0.06 Perf Half Y59.74%
Book/sh0.85 P/B1.00 EPS next Y- ROA-43.20% Target Price- Perf Year23.20%
Cash/sh0.32 P/C2.67 EPS next 5Y- ROE-44.30% 52W Range0.47 - 2.55 Perf YTD-2.35%
Dividend- P/FCF- EPS past 5Y66.60% ROI- 52W High-66.55% Beta1.59
Dividend %- Quick Ratio31.60 Sales past 5Y- Gross Margin- 52W Low83.20% ATR0.08
Employees3 Current Ratio31.60 Sales Q/Q- Oper. Margin- RSI (14)37.72 Volatility7.96% 9.23%
OptionableNo Debt/Eq0.00 EPS Q/Q-96.70% Profit Margin- Rel Volume0.09 Prev Close0.85
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume11.34M Price0.85
Recom- SMA20-8.92% SMA50-20.42% SMA200-6.39% Volume0 Change0.00%
May-13-21 09:00AM  
May-12-21 09:00AM  
May-11-21 09:00AM  
May-06-21 07:00AM  
Apr-27-21 10:00AM  
Apr-26-21 09:00AM  
Apr-22-21 09:00AM  
Apr-16-21 10:00AM  
Apr-07-21 09:00AM  
Apr-05-21 09:00AM  
Mar-29-21 09:00AM  
Mar-12-21 10:00AM  
Mar-04-21 09:00AM  
Mar-01-21 09:00AM  
Feb-23-21 10:56AM  
Feb-22-21 09:00AM  
Feb-19-21 11:10AM  
Feb-16-21 10:15PM  
Feb-03-21 09:00AM  
Feb-02-21 09:00AM  
Feb-01-21 08:00AM  
Jan-22-21 01:30PM  
Jan-11-21 08:30AM  
Jan-06-21 08:00AM  
Dec-09-20 10:00AM  
Nov-20-20 08:00AM  
Nov-13-20 09:00AM  
Nov-08-20 07:38AM  
Oct-28-20 01:30PM  
Sep-18-20 10:00AM  
Sep-11-20 10:00AM  
Aug-31-20 05:00PM  
Aug-18-20 09:00AM  
Aug-14-20 09:00AM  
Aug-11-20 10:00AM  
Aug-05-20 09:00AM  
Aug-03-20 10:00AM  
Jul-09-20 01:31PM  
Jun-26-20 10:30AM  
May-28-20 10:00AM  
May-19-20 10:00AM  
May-08-20 05:00PM  
May-06-20 01:30PM  
May-04-20 05:00PM  
Apr-30-20 02:33PM  
Apr-21-20 08:30AM  
Apr-20-20 08:30AM  
Apr-15-20 01:41PM  
Apr-14-20 12:08PM  
Mar-27-20 05:30PM  
Mar-26-20 10:15AM  
Mar-23-20 08:00PM  
Mar-18-20 12:52PM  
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The Company is also developing an antiviral platform that inhibits replication of multiple viruses, including influenza virus, SARS-CoV, MERS-CoV, Ebolavirus, and Marburg virus. It has a license agreement with the University of Texas; and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hayes AnthonyCEOMay 03Buy0.9910,0009,90078,430May 04 09:00 AM
Hayes AnthonyCEOApr 29Buy0.9910,0009,90068,430Apr 30 09:00 AM
Hayes AnthonyCEOApr 22Buy0.9310,0009,30058,430Apr 23 11:10 AM